Clinical

Dataset Information

0

4SC-201 (Resminostat) in Advanced Colorectal Carcinoma


ABSTRACT: The purpose of this study is to determine the Maximum Tolerated Dose (MTD) of 4SC-201 (Resminostat) in combination with FOLFIRI and whether 4SC-201 (Resminostat) is effective and safe in combination FOLFIRI versus FOLFIRI alone in the treatment of advanced colorectal carcinoma.

DISEASE(S): Colorectal Carcinoma,Advanced Or Metastasized Colorectal Carcinoma,Carcinoma,Advanced Colorectal Carcinoma,Colorectal Neoplasms

PROVIDER: 2100868 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2011-11-21 | E-GEOD-32035 | biostudies-arrayexpress
2014-02-04 | E-GEOD-54621 | biostudies-arrayexpress
2011-11-21 | GSE32035 | GEO
2014-02-04 | GSE54621 | GEO
2012-04-11 | E-GEOD-37180 | biostudies-arrayexpress
2015-11-11 | GSE66999 | GEO
| 2517000 | ecrin-mdr-crc
| 2175054 | ecrin-mdr-crc
2024-05-16 | GSE267621 | GEO
| 2112802 | ecrin-mdr-crc